NCT05470283 2026-04-16
Phase I, Open-Label, Study of Tumor Infiltrating Lymphocytes Engineered With Membrane Bound IL15 Plus Acetazolamide in Adult Patients With Metastatic Melanoma
M.D. Anderson Cancer Center
Phase 1 Active not recruiting
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
TILT Biotherapeutics Ltd.
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
University Health Network, Toronto